We review emerging strategies to protect the privacy of research participants in international epigenome research: open consent, genome donation, registered access, automated procedures, and privacy-enhancing technologies.
With the advent of the Human Genome Project and the emergence of next-generation sequencing (NGS) technologies, open data sharing has become increasingly popular within the scientific community. This model is now the norm for large scale ''OMICS'' research projects. In the context of epigenomic research, open science will facilitate the association of rich epigenetic datasets (such as DNA methylation, RNA expression, chromatin states, and conformation) with data on participants' medical and environmental exposure. These will provide a reference for studies of genetic and epigenetic events that underlie human development, diversity, and disease. The independent evaluation of robustness of analytical strategies and conclusions from experiments, a critical part of the scientific process, hinges on access to materials, which, in this case, are raw sequence files and associated metadata.
Although the open science model has made significant contributions to the progress of ''OMICS'' research, it has also met with resistance from some stakeholders. These include concerns from the private sector over intellectual property rights and from the data producers over attribution and recognition of their work. Another important critique comes from privacy advocates due to the inherently identifying nature of genetic information and the possibility for data misuse by third parties. A daunting challenge is the inevitable variation among the large number of data producers, most operating outside large international consortia, now having access to NGS technologies in all branches of life sciences. Researchers producing valuable data with public funding still lack familiarity with recent scientific norms applicable to governing, curating, and sharing big data. This can lead to delays in data sharing, as well as incomplete quality control.
The initial response from policymakers has been to propose an intermediate approach involving ''controlled access'' to potentially identifying human genomic data and associated metadata. This process requires, at a minimum, that researchers requesting access to the data complete an access agreement providing personal and institutional identification. Researchers are also required to describe the purpose of their research and commit to a number of good privacy and security practices for the processing of controlled data.
The controlled access approach is not a standalone, comprehensive method to ensure the complete protection of potentially identifying health data. Rather, controlled access should be deployed as part of an overall data privacy protection framework that includes state-of-the-art physical, administrative, and technical security safeguards working in conjunction with national and international privacy norms. It should also include the development of an effective compliance and accountability framework.
Yet, controlled access has been criticized by some members of the scientific community who believe that it represents a strong impediment to open science research. In an attempt to address this critique, other potential models have been proposed and implemented, such as open consent, genome donation, registered access, and the use of diverse privacy-enhancing technologies. However, these approaches have yet to gain broad acceptance from the international research community.
Based on the authors' experience as members of the International Cancer Genome Consortium (ICGC), the International Human Epigenome Consortium (IHEC), and the Global Alliance for Genomics and Health (GA4GH), this Commentary provides an overview of the trade-offs involved in controlledaccess approaches for epigenomics research and assesses the potential of various proposed alternatives.
It is particularly timely to discuss this in the field of epigenetics, where research is shifting from animal models to human participants. Epigenomic datasets are even richer and more informative than genomic data with sequence variation only, enhancing the benefits and exacerbating the challenges of open data sharing and making concerns about ethics and data security all the more relevant in this field. Members of IHEC have adopted a tiered strategy to sharing data, using a completely open access policy approach as a default and a controlled access approach where the sensitivity of the data requires greater care. The IHEC Bioethics Workgroup conducts research to support IHEC's data sharing policies and regularly evaluates the risks and benefits of evolving data sharing strategies (Dyke et al., 2016b) . 
